Ethical Challenges In Long-Term Funding For HIV/AIDS
Authors:
- 1 November 2009
- journal article
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 28 (6) , 1666-1676
Abstract
The global response to the AIDS pandemic aims for universal access to treatment and for pursuing every possible avenue to prevention. Skeptics, doubting that the huge increases in current funding levels needed for universal treatment will ever happen, would scale back antiretroviral treatment in favor of more cost-effective preventive interventions. Economics, politics, and science figure in this debate. But there is also a question of ethical principle: Is there a moral imperative to emphasize treatment, even if emphasizing prevention would save more lives? The authors examine moral arguments that address this question, and come down on the side of saving the most lives via prevention.Keywords
This publication has 7 references indexed in Scilit:
- Statistical vs. identified lives in benefit-cost analysisJournal of Risk and Uncertainty, 2007
- The Rule of RescueSocial Science & Medicine, 2003
- HIV prevention before HAART in sub-Saharan AfricaThe Lancet, 2002
- Setting Health Care Priorities in OregonJAMA, 1991
- 3. Bentham in a Box: Technology Assessment and Health Care AllocationLaw, Medicine and Health Care, 1986
- Discounting of Life-Saving and Other Nonmonetary EffectsManagement Science, 1983
- Statistical lives and the principle of maximum benefit.Journal of Medical Ethics, 1979